ROCKVILLE, Md., July 20, 2011 /PRNewswire/ -- Vanda
Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical
company focused on the development and commercialization of
products for central nervous system disorders, today announced it
will release results for the second quarter of 2011, on
Thursday, August 4, 2011, before the
market opens. A full text copy of the release will be disseminated
at that time.
Mihael H. Polymeropoulos, M.D.,
President and Chief Executive Officer, will host a conference call
to discuss the results at 10:00 AM ET
on Thursday, August 4, 2011.
Also participating on the call will be James Kelly, Senior Vice President and Chief
Financial Officer. To participate in the conference call,
dial the appropriate number below shortly before the 10:00 AM start time and ask for the Vanda
Pharmaceuticals conference call hosted by Dr. Polymeropoulos.
The teleconference dial-in numbers are as follows:
Domestic callers 1-866-314-5232
International callers 1-617-213-8052
Participant Passcode 16117516
The conference call will be broadcast simultaneously and
archived on the Company's website, www.vandapharma.com. Investors
should go to the website at least 15 minutes early to register,
download, and install any necessary audio software.
A replay of the call will be available on Thursday, August 4, 2011, beginning at
1:00 PM ET and will be accessible
until Thursday, August 11, 2011, at
5:00 PM ET. The replay call-in number
is 1-888-286-8010 for domestic callers and 1-617-801-6888 for
international callers. The access number is 57140859.
ABOUT VANDA PHARMACEUTICALS INC.:
Vanda Pharmaceuticals Inc. is a biopharmaceutical company
focused on the development and commercialization of products for
central nervous system disorders. For more on Vanda
Pharmaceuticals Inc., please visit http://www.vandapharma.com.
Company Contact:
Cristina Murphy
Communications Manager
Vanda Pharmaceuticals Inc.
(240) 599-4500
cristina.murphy@vandapharma.com
SOURCE Vanda Pharmaceuticals Inc.